M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum

European Journal of Neuroscience

Volumn 32, Issue 4, 2010, Pages 570-578

  Bachis, Alessia ^a   Cruz, Maria I ^a   Mocchetti, Italo ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BDNF; CCR5; CXCR4; gp120BaL; Microglia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 120 IIIB; GLYCOPROTEIN GP 120BAL; INTERLEUKIN 1BETA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN IMMUNODEFICIENCY VIRUS; MICROGLIA; NERVE CELL; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SOMATOSENSORY CORTEX; SUBSTANTIA NIGRA; VIRUS STRAIN;

ANIMALS; APOPTOSIS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; HIV ENVELOPE PROTEIN GP120; HUMANS; MALE; MICROGLIA; NEURONS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR5; RECEPTORS, CXCR4;

EID: 77955763273     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07325.x     Document Type: Article

References (72)

1. Adamson, D.C., Wildemann, B., Sasaki, M., Glass, J.D., McArthur, J.C., Christov, V.I., Dawson, T.M. Dawson, V.L. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science, 274, 1917 1921.
2. Adle-Biassette, H., Levy, Y., Colombel, M., Poron, F., Natchev, S., Keohane, C. Gray, F. (1995) Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol., 21, 218 227.
3. Ahmed, F., Tessarollo, L., Thiele, C. Mocchetti, I. (2008) Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res., 1227, 1 11.
4. Albright, A.V., Shieh, J.T., Itoh, T., Lee, B., Pleasure, D., O'Connor, M.J., Doms, R.W. Gonzalez-Scarano, F. (1999) Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J. Virol., 73, 205 213.
5. Altar, C.A., Boylan, C.B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S.J., Lindsay, R.M. Hyman, C. (1992) Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA, 89, 11347 11351.
6. Altar, C.A., Cai, N., Bliven, T., Juhasz, M., Conner, J.M., Acheson, A.L., Lindsay, R.M. Wiegand, S.J. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature, 389, 856 860.
7. Bachis, A. Mocchetti, I. (2005) Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins. Ann. N.Y. Acad. Sci., 1053, 247 257.
8. Bachis, A., Major, E.O. Mocchetti, I. (2003) Brain-derived neurotrophic factor inhibits human immunodeficiency virus-1/gp120-mediated cerebellar granule cell death by preventing gp120 internalization. J. Neurosci., 23, 5715 5722.
9. Bachis, A., Aden, S.A., Nosheny, R.L., Andrews, P.M. Mocchetti, I. (2006) Axonal transport of human immunodeficiency virus type 1 envelope glycoprotein 120 is found in association with neuronal apoptosis. J. Neurosci., 26, 6771 6780.
10. Bachis, A., Biggio, F., Major, E.O. Mocchetti, I. (2009) M- and T-tropic HIVs promote apoptosis in rat neurons. J. Neuroimmune. Pharmacol., 4, 150 160.
11. Bagetta, G., Corasaniti, M.T., Aloe, L., Berliocchi, L., Costa, N., Finazzi-Agro, A. Nistico, G. (1996) Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. Natl. Acad. Sci. USA, 93, 928 933.
12. Banisadr, G., Fontanges, P., Haour, F., Kitabgi, P., Rostene, W. Parsadaniantz, S.M. (2002) Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci., 16, 1661 1671.
13. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 273, 289 290.
14. Berger, J.R. Arendt, G. (2000) HIV dementia: the role of the basal ganglia and dopaminergic systems. J. Psychopharmacol., 14, 214 221.
15. Berger, E.A., Murphy, P.M. Farber, J.M. (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol., 17, 657 700.
16. Bezzi, P., Domercq, M., Brambilla, L., Galli, R., Schols, D., De Clercq, E., Vescovi, A., Bagetta, G., Kollias, G., Meldolesi, J. Volterra, A. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci., 4, 702 710.
17. Bissel, S.J. Wiley, C.A. (2004) Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations. Brain Pathol., 14, 97 108.
18. Brandoli, C., Sanna, A., De Bernardi, M.A., Follesa, P., Brooker, G. Mocchetti, I. (1998) Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J. Neurosci., 18, 7953 7961.
19. Choi-Lundberg, D.L., Lin, Q., Chang, Y.N., Chiang, Y.L., Hay, C.M., Mohajeri, H., Davidson, B.L. Bohn, M.C. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science, 275, 838 841.
20. Eugenin, E.A., D'Aversa, T.G., Lopez, L., Calderon, T.M. Berman, J.W. (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem., 85, 1299 1311.
21. Floyd, R.A. (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med., 222, 236 245.
22. Gallo, P., Frei, K., Rordorf, C., Lazdins, J., Tavolato, B. Fontana, A. (1989) Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol., 23, 109 116.
23. Gelbard, H.A. Epstein, L.G. (1995) HIV-1 encephalopathy in children. Curr. Opin. Pediatr., 7, 655 662.
24. Glass, J.D., Wesselingh, S.L., Selnes, O.A. McArthur, J.C. (1993) Clinical-neuropathologic correlation in HIV-associated dementia. Neurology, 43, 2230 2237.
25. Gray, L., Roche, M., Churchill, M.J., Sterjovski, J., Ellett, A., Poumbourios, P., Sherieff, S., Wang, B., Saksena, N., Purcell, D.F., Wesselingh, S., Cunningham, A.L., Brew, B.J., Gabuzda, D. Gorry, P.R. (2009) Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain. J. Virol., 83, 5430 5441.
26. Grivel, J.C. Margolis, L.B. (1999) CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med., 5, 344 346.
27. Hagg, T. (1998) Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. Neurol., 149, 183 192.
28. Harouse, J.M., Gettie, A., Tan, R.C., Blanchard, J. Cheng-Mayer, C. (1999) Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science, 284, 816 819.
29. He, J., Chen, Y., Farzan, M., Choe, H., Ohagen, A., Gartner, S., Busciglio, J., Yang, X., Hofmann, W., Newman, W., Mackay, C.R., Sodroski, J. Gabuzda, D. (1997) CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 385, 645 649.
30. Hesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson, D.L. Horuk, R. (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol., 8, 595 598.
31. Heyes, M.P., Brew, B., Martin, A., Markey, S.P., Price, R.W., Bhalla, R.B., Salazar, A. (1991) Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Adv. Exp. Med. Biol., 294, 687 690.
32. Hyman, C., Hofer, M., Barde, Y.A., Juhasz, M., Yancopoulos, G.D., Squinto, S.P. Lindsay, R.M. (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 350, 230 232.
33. Kaul, M. Lipton, S.A. (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 96, 8212 8216.
34. Kaul, M., Garden, G.A. Lipton, S.A. (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410, 988 994.
35. Kaul, M., Ma, Q., Medders, K.E., Desai, M.K. Lipton, S.A. (2007) HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ., 14, 296 305.
36. Koutsilieri, E., Sopper, S., Scheller, C., ter Meulen, V. Riederer, P. (2002) Parkinsonism in HIV dementia. J. Neural. Transm., 109, 767 775.
37. Kume, T., Kouchiyama, H., Kaneko, S., Maeda, T., Akaike, A., Shimohama, S., Kihara, T., Kimura, J., Wada, K. Koizumi, S. (1997) BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons. Brain Res., 756, 200 204. (Pubitemid 27241627)
38. Letendre, S.L., Lanier, E.R. McCutchan, J.A. (1999) Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J. Infect. Dis., 180, 310 319.
39. Lindholm, D., Dechant, G., Heisenberg, C.P. Thoenen, H. (1993) Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity. Eur. J. Neurosci., 5, 1455 1464.
40. Marini, A.M., Rabin, S.J., Lipsky, R.H. Mocchetti, I. (1998) Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J. Biol. Chem., 273, 29394 29399.
41. Masliah, E., Ge, N. Mucke, L. (1996) Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol., 10, 57 67.
42. Mastroianni, C.M., Paoletti, F., Valenti, C., Vullo, V., Jirillo, E. Delia, S. (1992) Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection. J. Neurol. Neurosurg. Psychiatry, 55, 219 221.
43. McDyer, J.F., Dybul, M., Goletz, T.J., Kinter, A.L., Thomas, E.K., Berzofsky, J.A., Fauci, A.S. Seder, R.A. (1999) Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. J. Immunol., 162, 3711 3717.
44. van der Meer, P., Ulrich, A.M., Gonzalez-Scarano, F. Lavi, E. (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp. Mol. Pathol., 69, 192 201.
45. Meucci, O., Fatatis, A., Simen, A.A., Bushell, T.J., Gray, P.W. Miller, R.J. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA, 95, 14500 14505.
46. Mocchetti, I. Brown, M. (2008) Targeting neurotrophin receptors in the central nervous system. CNS Neurol. Disord, Drug Targets, 7, 71 82.
47. Nagatsu, T., Mogi, M., Ichinose, H. Togari, A. (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural. Transm. Suppl., 60, 277 290.
48. Nath, A. Berger, J. (2004) HIV dementia. Curr Treat Options Neurol, 6, 139 151.
49. Nosheny, R.L., Bachis, A., Acquas, E. Mocchetti, I. (2004) Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur. J. Neurosci., 20, 2857 2864.
50. Nosheny, R.L., Bachis, A., Aden, S.A., De Bernardi, M.A. Mocchetti, I. (2006) Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra. J. Neurobiol., 66, 1311 1321.
51. Nosheny, R.L., Amhed, F., Yakovlev, A.G., Meyer, E.M., Ren, K., Tessarollo, L. Mocchetti, I. (2007) Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo. Eur. J. Neurosci., 25, 2275 2284. (Pubitemid 46625935)
52. Ogura, K., Ogawa, M. Yoshida, M. (1994) Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. Neuroreport, 5, 1224 1226.
53. Paxinos, G. Watson, C. (1998) The rat brain in stereotaxic coordinates. Academic Press, San Diego, CA.
54. Paxton, W.A., Neumann, A.U., Kang, S., Deutch, L., Brown, R.C., Koup, R.A. Wolinsky, S.M. (2001) RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression. J. Infect. Dis., 183, 1678 1681.
55. Perry, V.H., Matyszak, M.K. Fearn, S. (1993) Altered antigen expression of microglia in the aged rodent CNS. Glia, 7, 60 7.
56. Persidsky, Y., Buttini, M., Limoges, J., Bock, P. Gendelman, H.E. (1997) An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J. Neurovirol., 3, 401 416.
57. Petito, C.K., Roberts, B., Cantando, J.D., Rabinstein, A. Duncan, R. (2001) Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J. Neuropathol. Exp. Neurol., 60, 377 385.
58. Pierson, T.C., Doms, R.W. Pohlmann, S. (2004) Prospects of HIV-1 entry inhibitors as novel therapeutics. Rev. Med. Virol., 14, 255 270.
59. Power, C., McArthur, J.C., Johnson, R.T., Griffin, D.E., Glass, J.D., Perryman, S. Chesebro, B. (1994) Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol., 68, 4643 4649.
60. Power, C., McArthur, J.C., Nath, A., Wehrly, K., Mayne, M., Nishio, J., Langelier, T., Johnson, R.T. Chesebro, B. (1998) Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J. Virol., 72, 9045 9053.
61. Price, R.W. (1996) Neurological complications of HIV infection. Lancet, 348, 445 452.
62. Price, R.W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A.C. Cleary, P. (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science, 239, 586 592.
63. Raivich, G., Jones, L.L., Werner, A., Bluthmann, H., Doetschmann, T. Kreutzberg, G.W. (1999) Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochir. Suppl., 73, 21 30.
64. Rottman, J.B., Ganley, K.P., Williams, K., Wu, L., Mackay, C.R. Ringler, D.J. (1997) Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol., 151, 1341 1351.
65. Saha, K., Bentsman, G., Chess, L. Volsky, D.J. (1998) Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J. Virol., 72, 876 881.
66. Sozzani, S., Introna, M., Bernasconi, S., Polentarutti, N., Cinque, P., Poli, G., Sica, A. Mantovani, A. (1997) MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression. J. Leukoc. Biol., 62, 30 3.
67. Trecki, J., Brailoiu, G.C. Unterwald, E.M. (2010) Localization of CXCR4 in the forebrain of the adult rat. Brain Res., 1315, 53 62.
68. Tyor, W.R., Glass, J.D., Griffin, J.W., Becker, P.S., McArthur, J.C., Bezman, L. Griffin, D.E. (1992) Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol., 31, 349 360.
69. Viviani, B., Gardoni, F., Bartesaghi, S., Corsini, E., Facchi, A., Galli, C.L., Di Luca, M. Marinovich, M. (2006) Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J. Biol. Chem., 281, 30212 30222.
70. Westmoreland, S.V., Alvarez, X., deBakker, C., Aye, P., Wilson, M.L., Williams, K.C. Lackner, A.A. (2002) Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J. Neuroimmunol., 122, 146 158.
71. Zanussi, S., D'Andrea, M., Simonelli, C., Tirelli, U. De Paoli, P. (1996) Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. AIDS, 10, 1431 1432.
72. Zheng, J., Thylin, M.R., Ghorpade, A., Xiong, H., Persidsky, Y., Cotter, R., Niemann, D., Che, M., Zeng, Y.C., Gelbard, H.A., Shepard, R.B., Swartz, J.M. Gendelman, H.E. (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol., 98, 185 200.